Second US Commercial Customer - Northeast Georgia
Filed with ASX · · 3 pages · English
PERTH, Australia, 08 December 2025: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology company commercialising its Salix® AI-powered cloud platform, for the near real time, point of care assessment and management of coronary artery disease, is pleased to announce it has secured its second U.S. customer with the signing of a commercial agreement for the use of its Salix® platfo
Earlier from Artrya
- S&P DJI Announces December 2025 Quarterly Rebalance
- SAPPHIRE Study Expands With Inclusion of Ascension
- Mass General Brigham to Participate in SAPPHIRE Study
- Completion of Placement and Cleansing Notice
- Completion of Share Purchase Plan
Later from Artrya
- First Revenues from Salix Coronary Plaque Module
- Cone Health Becomes Third U.S. Customer
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D and Interim Financial Report
- S&P DJI Announces March 2026 Quarterly Rebalance
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya